Skip to main content

Prognosis

  • Chapter
  • First Online:
  • 602 Accesses

Abstract

Just like most of the functional gastrointestinal disorders, functional dyspepsia (FD) is a benign disorder. Its natural history is not marked by significant complications, such as peptic ulcer bleeding or perforation, and it has no mortality. In spite of this, FD is a chronic, long-lasting, and sometimes recurrent condition representing a significant symptomatic burden, causing impairment in the quality of life of the patients and high costs for society. In this chapter, natural course, prevalence, and risk of peptic ulcer and gastric cancer in FD will be analyzed.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Misiewicz JJ. Dyspepsia. In: Feldman M, Scharschmidt BF, editors. Sleisenger and Fordtran’s gastrointestinal and liver disease. 5th ed. Philadelphia, PA: WB Saunders; 1993. p. 572–9.

    Google Scholar 

  2. McQuaid KR. Dyspepsia. In: Feldman M, Friedman LS, Sleisenger MH, editors. Sleisenger and Fordtran’s gastrointestinal and liver disease. 7th ed. Philadelphia, PA: WB Saunders; 2002. p. 102–18.

    Google Scholar 

  3. Metz DV. Dyspepsia. In: Brand LJ, editor. Clinical practice of gastroenterology. 1st ed. Philadelphia, PA: Churchill Livingstone; 1999. p. 226–34.

    Google Scholar 

  4. Keller J, Layer P. Dyspepsie. In: Riemann JF, Fischbach W, Galle PR, Mössner J, editors. Gastroenterologie. 1st ed. Stuttgart: Georg Thieme; 2007. p. 505–14.

    Google Scholar 

  5. Vakil NB, Talley NJ. Dyspepsia. In: Talley NJ, Locke III RG, Saito YA, editors. GI epidemiology. 1st ed. Oxford: Blackwell Publishing; 2007. p. 143–8.

    Chapter  Google Scholar 

  6. Bytzer P, Talley NJ. Dyspepsia. Ann Intern Med. 2001;134:815–22.

    PubMed  CAS  Google Scholar 

  7. Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. In: Drossman DA, editor. Rome III: the functional gastrointestinal disorders. 3rd ed. McLean, VA: Degnon Associates Inc.; 2006. p. 419–87.

    Google Scholar 

  8. Talley NJ, McNeil D, Hayden A, Colreavy C, Piper DW. Prognosis of chronic unexplained dyspepsia. A prospective study of potential predictor variables in patients with endoscopically diagnosed nonulcer dyspepsia. Gastroenterology. 1987;92:1060–6.

    PubMed  CAS  Google Scholar 

  9. Agréus L, Svärdsudd K, Talley NJ, Jones MP, Tibblin G. Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol. 2001;96:2905–14.

    PubMed  Google Scholar 

  10. Heikkinnen M, Färkkilä M. What is the long-term outcome of the different subgroups of functional dyspepsia? Aliment Pharmacol Ther. 2003;18:223–9.

    Article  Google Scholar 

  11. El-Serag HB, Talley NJ. Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther. 2004;19:643–54.

    Article  PubMed  CAS  Google Scholar 

  12. Sloth H, Jorgensen LS. Predictors for the course of chronic non-organic upper abdominal pain. Scand J Gastroenterol. 1989;24:440–4.

    Article  PubMed  CAS  Google Scholar 

  13. Bonnevie O. Outcome of non-ulcer disease. Scand J Gastroenterol Suppl. 1982;79:135–8.

    PubMed  CAS  Google Scholar 

  14. Thompson WG. Nonulcer dyspepsia. Can Med Assoc J. 1984;130:565–9.

    PubMed  CAS  Google Scholar 

  15. Brummer P, Hakkinen I. X-ray negative dyspepsia: a follow-up study. Acta Med Scand. 1959;165:329–32.

    Article  PubMed  CAS  Google Scholar 

  16. Krag E. Pseudo-ulcer and true peptic ulcer. A clinical, radiographic and statistical follow-up study. Acta Med Scand. 1965;178:713–28.

    Article  PubMed  CAS  Google Scholar 

  17. Gregory DW, Davies GT, Evans KT, Rhodes J. Natural history of patients with X-ray-negative dyspepsia in general practice. Br Med J. 1972;4:519–20.

    Article  PubMed  CAS  Google Scholar 

  18. Lindell GH, Celebioglu F, Graffner HO. Non-ulcer dyspepsia in the long-term perspective. Eur J Gastroenterol Hepatol. 1995;7:829–33.

    PubMed  CAS  Google Scholar 

  19. Asfeldt AM, Steigen SE, Løchen ML, et al. The natural course of Helicobacter pylori infection on endoscopic findings in a population during 17 years of follow-up: the Sørreisa gastrointestinal disorder study. Eur J Epidemiol. 2009;24:649–58.

    Article  PubMed  Google Scholar 

  20. Rosenstock S, Jørgensen T, Bonnevie O, Andersen L. Risk factors for peptic ulcer disease: a population based prospective cohort study comprising 2416 Danish adults. Gut. 2003;52:186–93.

    Article  PubMed  CAS  Google Scholar 

  21. Andersen IB, Bonnevie O, Jørgensen T, Sørensen TI. Time trends for peptic ulcer disease in Denmark, 1981–1993. Analysis of hospitalization register and mortality data. Scand J Gastroenterol. 1998;33:260–6.

    Article  PubMed  CAS  Google Scholar 

  22. Groenen MJ, Kuipers EJ, Hansen BE, Ouwendijk RJ. Incidence of duodenal ulcers and gastric ulcers in a Western population: back to where it started. Can J Gastroenterol. 2009;23:604–8.

    PubMed  Google Scholar 

  23. Cai S, Garciá Rodriquez LA, Massó-González EL, Hernández-Diaz Z. Uncomplicatedpeptic ulcer in the UK: trends from 1997 to 2005. Aliment Pharmacol Ther. 2009;30:1039–48.

    Article  PubMed  CAS  Google Scholar 

  24. Sung JJ, Kuipers EJ, El-Serag HB. Systematic review: the global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther. 2009;29:938–46.

    Article  PubMed  CAS  Google Scholar 

  25. Maconi G, Manes G, Porro GB. Role of symptoms in diagnosis and outcome of gastric cancer. World J Gastroenterol. 2008;14:1149–55.

    Article  PubMed  Google Scholar 

  26. Vakil N, Moayyedi P, Fennerty MB, Talley NJ. Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and meta-analysis. Gastroenterology. 2006;131:390–401.

    Article  PubMed  Google Scholar 

  27. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784–9.

    Article  PubMed  CAS  Google Scholar 

  28. Boldys H, Marek TA, Wanczura P, Matusik P, Nowak A. Even young patients with no alarm symptoms should undergo endoscopy for earlier diagnosis of gastric cancer. Endoscopy. 2003;35:61–7.

    Article  PubMed  CAS  Google Scholar 

  29. Liou JM, Lin JT, Wang HP, et al. The optimal age threshold for screening upper endoscopy for uninvestigated dyspepsia in Taiwan, an area with a higher prevalence of gastric cancer in young adults. Gastrointest Endosc. 2005;61:819–25.

    Article  PubMed  Google Scholar 

  30. Bowrey DJ, Griffin SM, Wayman J, Karat D, Hayes N, Raimes SA. Use of alarm symptoms to select dyspeptics for endoscopy causes patients with curable esophagogastric cancer to be overlooked. Surg Endosc. 2006;20:1725–8.

    Article  PubMed  CAS  Google Scholar 

  31. Uehara G, Nago A, Espinoza R, et al. Optimal age for gastric cancer screening in patients with dyspepsia without alarm symptoms. Rev Gastroenterol Perú. 2007;27:339–48.

    PubMed  Google Scholar 

  32. Muller LB, Fagundes RB, Moraes CC, Rampazzo A. Prevalence of Helicobacter pylori infection and gastric cancer precursor lesions in patients with dyspepsia. Arq Gastroenterol. 2007;44:93–8.

    Article  PubMed  Google Scholar 

  33. Sundar N, Muraleedharan V, Pandit J, Green JT, Crimmins R, Swift GL. Does endoscopy diagnose early gastrointestinal cancer in patients with uncomplicated dyspepsia? Postgrad Med J. 2006;82:52–4.

    Article  PubMed  CAS  Google Scholar 

  34. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol. 2006;21:354–62.

    Google Scholar 

  35. Ito M, Takata S, Tatsugami M, et al. Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: a systematic review. J Gastroenterol. 2009;44:365–71.

    Article  PubMed  Google Scholar 

  36. Leja M, Kupcinskas L, Funka K, et al. The validity of a biomarker method for indirect detection of gastric mucosal atrophy versus standard histopathology. Dig Dis Sci. 2009;54:2377–84.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to György Miklós Buzás .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media LLC

About this chapter

Cite this chapter

Buzás, G.M. (2011). Prognosis. In: Duvnjak, M. (eds) Dyspepsia in Clinical Practice. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1730-0_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-1730-0_12

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-1729-4

  • Online ISBN: 978-1-4419-1730-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics